Boehringer closing Petersburg API plant
September 25, 2012Manufacturing and Production API, Boehringer, Petersburg, chemicals
Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …
Pharma is recovering, says Moody’s
September 25, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma
Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
Life Healthcare Communications appoints Lyndsey Wright
September 25, 2012Business Services, Medical Communications, Sales and Marketing Life healthcare communications, Lyndsey Wright
Life Healthcare Communications has expanded its client services department to meet demand with the appointment of a new senior account …
Eisai opens Fycompa UK manufacturing line
September 25, 2012Manufacturing and Production, Sales and Marketing Eisai, Fycompa
Eisai has opened a new solid dose production line for epilepsy drug Fycompa at its UK base in Hatfield, Hertfordshire. …
John LaMattina: Why was bapineuzamab moved into Phase III trials?
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab
The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Contract research news in brief
September 24, 2012Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
EC publishes trio of revised GMP Guide sections
September 24, 2012Manufacturing and Production EC, EU, GMP, ICH
The European Commission has published two revised chapters in its Good Manufacturing Practice (GMP) Guide, along with an update of …
Eliquis receives nod in AF
September 24, 2012Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
CMO market on the up says new study
September 24, 2012Manufacturing and Production API, CMO, manufacturing
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Amgen names Ray Jordan senior VP Corporate Affairs
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan
Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
New possibility for Lilly erectile drug
September 24, 2012Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly
Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
China sees fresh wave of drug price cuts
September 21, 2012Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing
China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …
Transgene appoints Nathalie Adda as chief medical officer
September 21, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene
Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …
Merz Pharma slammed by PMCPA
September 21, 2012Medical Communications, Sales and Marketing ABPI, Merz Pharma, PMCPA
Merz Pharma UK has been rapped over the knuckles for three of the most serious breaches it is possible to …
Almirall’s COPD drug launched in Europe
September 20, 2012Sales and Marketing Advair, Almirall, Eklira, Genuair, Seretide, Spiriva
Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …
Teva announces appointment of Prof Itzhak Krinsky
September 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Itzhak Krinsky, Teva
Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …
Sanofi cleared in sales row
September 20, 2012Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi
Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …
Boehringer submits new lung cancer drug
September 20, 2012Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib
Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …
Sandra Peterson joins J&J’s executive committee
September 20, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson
Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
